How to use D-dimer in acute cardiovascular care

European Heart Journal: Acute Cardiovascular Care

Volumn 6, Issue 1, 2017, Pages 69-80

  Giannitsis, Evangelos ^a   Mair, Johannes ^b   Christersson, Christina ^c   Siegbahn, Agneta ^c   Huber, Kurt ^d   Jaffe, Allan S ^e   Peacock, W Frank ^f   Plebani, Mario ^g   Thygesen, Kristian ^h   Möckel, Martin ⁱ   Mueller, Christian ^j   Lindahl, Bertil ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UPPSALA UNIVERSITY   (Sweden)

^d WILHELMINEN HOSPITAL   (Austria)

^e MAYO CLINIC   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g University Hospital   (Italy)

^h AARHUS UNIVERSITY HOSPITAL   (Denmark)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

acute cardiovascular care; D dimer; pulmonary embolism; thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10A; D DIMER; FIBRIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AORTA DISSECTION; ARTICLE; ATRIAL FIBRILLATION; BLOOD CLOTTING; CANCER PATIENT; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CROSS LINKING; DEEP VEIN THROMBOSIS; DEGRADATION; ELECTROCARDIOGRAPHY; EMERGENCY CARE; ENZYME LINKED IMMUNOFLUORESCENCE ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; LATEX ENHANCED IMMUNOASSAY; LATEX PARTICLE BASED IMMUNOASSAY; LUNG ANGIOGRAPHY; LUNG EMBOLISM; PARTITION IMMUNOASSAY; POINT OF CARE TESTING; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TURBIDOMETRIC ASSAY; VEIN EMBOLISM; ALGORITHM; FEMALE; MALE; METABOLISM; POINT OF CARE SYSTEM; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

ALGORITHMS; BIOMARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; POINT-OF-CARE SYSTEMS; PULMONARY EMBOLISM; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOSIS;

EID: 85050577559     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872615610870     Document Type: Article

References (78)

1. Dahlback B. Blood coagulation. Lancet 2000; 355: 1627–1632.
2. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165–174.
3. Macfarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498–499.
4. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310–1312.
5. Mager JJ, Schutgens RE, Haas FJ. The early course of D-dimer concentration following pulmonary artery embolisation. Thromb Haemost 2001; 86: 1578–1579
6. Kario K, Matsuo T, Kobayashi H. Which factors affect high D-dimer levels in the elderly? Thromb Res 1991; 62: 501–508.
7. Lee AJ, Fowkes GR, Lowe GD. Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1995; 15: 1094–1097.
8. Tataru MC, Heinrich J, Junker R. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J 1999; 20: 1493–1502.
9. Rylatt DB, Blake AS, Cottis LE. An immunoassay for human D dimer using monoclonal antibodies. Thromb Res 1983; 31: 767–778.
10. Dempfle CE. Validation, calibration, and specificity of quantitative D-dimer assays. Semin Vasc Med 2005; 5: 315–320.
11. Eisenberg PR, Jaffe AS, Stump DC. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. Circulation 1990; 82: 1159–1168.
12. Stein PD, Hull RD, Patel KC. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: A systematic review. Ann Intern Med 2004; 140: 589–602.
13. Di Nisio M, Squizzato A, Rutjes AWS. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: A systematic review. J Thromb Haemost. 2007; 52: 296–304.
14. Apple FS, Jesse RL, Newby LK, ; National Academy of Clinical Biochemistry; IFCC Committee for Standardization of Markers of Cardiac Damage. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007; 115: e352–e355.
15. Geersing GJ, Toll DB, Janssen KJ. Diagnostic accuracy and user-friendliness of 5 point-of-care D-dimer tests for the exclusion of deep vein thrombosis. Clin Chem 2010; 56: 1758–1766.
16. Clinical and Laboratory Standards Institute (CLSI). Quantitative D-dimer for the exclusion of venous thromboembolic disease: Approved guideline. CLSI document H59-A. Wayne, PA: CLSI, 2011.
17. Geersing GJ, Janssen KJ, Oudega R. Excluding venous thromboembolism using point of care D-dimer tests in outpatients: A diagnostic meta-analysis. Br Med J 2009; 339: b2990.
18. CLSI. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays: Approved guideline. 5th ed. CLSI document H21-A5. Wayne, PA: CLSI, 2008.
19. Lippi G, Cervellin G, Casagranda I. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med 2014; 52: 621–628.
20. Bounameaux H, Cirafici P, de Moerloose P. Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 1991; 337: 196–200.
21. Wells PS, Anderson DR, Rodger M. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227–1235.
22. Lagerstedt CI, Olsson CG, Fagher BO. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985; 2: 515–518.
23. Palareti G, Cosmi B, Legnani C. PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780–1789.
24. Verhovsek M, Douketis JD, Yi Q. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008; 149: 481–490.
25. Wada H, Thachil J, Di Nisio M, ; The Scientific Standardization Committee on DIC of the International Society on Thrombosis Haemostasis. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost 2013; 11: 761–767.
26. van der Graaf F, van den Borne H, van der Kolk M. Exclusion of deep venous thrombosis with D-dimer testing–comparison of 13 D-dimer methods in 99 outpatients suspected of deep venous thrombosis using venography as reference standard. Thromb Haemost 2000; 83: 191–198.
27. Di Nisio M., Squizzato A, Rutjes AW. Diagnostic accuracy of D dimer test for exclusion of venous thromboembolism: A systematic review. J Thromb Haemost 2007; 5: 296–304.
28. Goodacre S, Sampson FC, Sutton AJ. Variation in the diagnostic performance of Ddimer for suspected deep vein thrombosis. QJM 2005; 98: 513–527.
29. Brill-Edwards P, Lee A. D-dimer testing in the diagnosis of acute venous thromboembolism. Thromb Haemost 1999; 82: 688–694.
30. Dempfle CE. Use of D-dimer assays in the diagnosis of venous thrombosis. Semin Thromb Hemost 2000; 26: 631–641.
31. Perrier A, Desmarais S, Miron MJ. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet 1999; 353: 190–195.
32. van Belle A, Büller HR, Huisman MV. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295: 172–179.
33. Söhne M, Kamphuisen PW, van Mierlo PJ. Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients. Thromb Haemost 2005; 94: 206–210.
34. Wells PS, Anderson DR, Rodger M. Excluding pulmonary embolism at the bedside without diagnostic imaging: Management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med 2001; 135: 98–107.
35. Wells PS, Hirsh J, Anderson DR. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326–1330.
36. Wicki J, Perneger TV, Junod AF. Assessing clinical probability of pulmonary embolism in the emergency ward: A simple score. Arch Intern Med 2001; 161: 92–97.
37. Le Gal G, Righini M, Roy PM. Prediction of pulmonary embolism in the emergency department: The revised Geneva score. Ann Intern Med 2006; 144: 165–171.
38. Klok FA, Mos IC, Nijkeuter M. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med 2008; 168: 2131–2136.
39. Janssen KJ, van der Velde EF, Ten Cate AJ. Optimisation of the diagnostic strategy for suspected deep-vein thrombosis in primary care. Thromb Haemost 2011; 105: 154–160.
40. Oudega R, Hoes AW, Toll DB. The value of clinical findings and D-dimer tests in diagnosing deep vein thrombosis in primary care. Semin Thromb Hemost 2006; 32: 673–677.
41. Lucassen W, Geersing GJ, Erkens PM. Clinical decision rules for excluding pulmonary embolism: A meta-analysis. Ann Intern Med 2011; 155: 448–460.
42. Geersing GJ, Zuithoff NP, Kearon C. Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: Individual patient data meta-analysis. Br Med J 2014; 348: g1340.
43. Bates SM, Jaeschke R, Stevens SM. American College of Chest Physicians. Diagnosis of DVT: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e351S–e418S.
44. National Institute for Health and Care Excellence. CG144 venous thromboembolic diseases: Two-level Wells score – templates for deep vein thrombosis and pulmonary embolism, http://guidance.nice.org.uk/CG144/TemplateWellsScore/doc/English (accessed 29 August 2013).
45. Konstantinides S, Torbicki A, Agnelli G.; Authors/Task Force Members.2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014; 35: 3033–3069.
46. Linkins LA, Bates SM, Lang E. elective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis. A randomized trial. Ann Intern Med 2013; 158: 93–100.
47. Kruip MJ, Slob MJ, Schijen JH. Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: A prospective management study. Arch Intern Med 2002; 162: 1631–1635.
48. Tick LW, Nijkeuter M, Kramer MH.; Christopher study investigators. High D-dimer levels increase the likelihood of pulmonary embolism. J Intern Med 2008; 264: 195–200.
49. Douma RA, Kamphuisen PW, Huisman MV. False normal results on multidetector row spiral computed tomography in patients with high clinical probability of pulmonary embolism. J Thromb Haemost 2008; 6: 1978–1979.
50. Stein PD, Fowler SE, Goodman LR. PIOPED II investigators. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006; 354: 2317–2327.
51. Righini M, Goehring C, Bounameaux H. Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med 2000; 109: 357–361.
52. Di Nisio M, Sohne M, Kamphuisen PW. D-dimer test in cancer patients with suspected acute pulmonary embolism.J Thromb Haemost 2005; 3: 1239–1242.
53. Righini M, Le Gal G, De Lucia S. Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb Haemost 2006; 95: 715–719.
54. Miron MJ, Perrier A, Bounameaux H. Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients. Eur Respir J 1999; 13: 1365–1370.
55. Chabloz P, Reber G, Boehlen F. TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol 2001; 115: 150–152.
56. Francalanci I, Comeglio P, Liotta AA. D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res 1995; 78: 399–405.
57. Rumley A, Emberson JR, Wannamethee SG. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years. J Thromb Haemost 2006; 4: 982–987.
58. Douma RA, le Gal G, Söhne M. Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: A retrospective analysis of three large cohorts. Br Med J 2010; 340: c1475.
59. Schouten HJ, Geersing GJ, Koek HL. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: Systematic review and meta-analysis. Br Med J 2013; 346: f2492.
60. Righini M, Van Es J, Den Exter PL. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014; 311: 1117–1124.
61. Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: New diagnostic thresholds are needed. Clin Chem 2005; 51: 825–829.
62. Epiney M, Boehlen F, Boulvain M. D-dimer levels during delivery and the postpartum. J Thromb Haemost 2005; 3: 268–271.
63. Carrier M, Lee AY, Bates SM. Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients. Thromb Res 2008; 123: 177–183.
64. Lee AY, Julian JA, Levine MN. Clinical utility of a rapid whole-blood D-dimer assay in patients with cancer who present with suspected acute deep venous thrombosis. Ann Intern Med 1999; 131: 417–423.
65. Shimony A, Filion KB, Mottillo S. Metaanalysis of usefulness of D-dimer to diagnose acute aortic dissection. Am J Cardiol 2011; 107: 1227–1234.
66. Sodeck G, Domanovits H, Schillinger M. A D-dimer in ruling out acute aortic dissection: A systematic review and prospective cohort study. Eur Heart J 2007; 28: 3067–3075.
67. Marill KA. Serum D-dimer is a sensitive test for the detection of acute aortic dissection: A pooled meta-analysis.J Emerg Med 2008; 34: 367–376.
68. Oldgren J, Linder R, Grip L. Coagulation activity and clinical outcome in unstable coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 1059–1064.
69. Tello-Montoliu A, Marin F, Roldan V. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: Implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med 2007; 262: 651–658.
70. Christersson C, Oldgren J, Bylock A. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: Observations from the ESTEEM Trial. Eur Heart J 2007; 28: 692–698.
71. Watson T, Shantsila E, Lip GY. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation. Int J Cardiol 2007; 120: 123–124; author reply 125–126.
72. Habara S, Dote K, Kato M. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007; 28: 2217–2222.
73. Lip GY, Nieuwlaat R, Pisters R. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 2010; 137: 263–272.
74. Sadanaga T, Sadanaga M, Ogawa S. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol 2010; 55: 2225–2231.
75. Christersson C, Wallentin L, Andersson U. D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial. J Thromb Haemost 2014; 12: 1404–1412.
76. Hijazi Z, Oldgren J, Siegbahn A. Biomarkers in atrial fibrillation: A clinical review. Eur Heart J 2013; 34: 1475–1480.
77. Tripodi A. D-dimer testing in laboratory practice. Clin Chem 2011; 57: 1256–1262.
78. Dempfle CE. D-dimer testing and venous thromboembolism: Four view points. J Thromb Haemost 2005; 3: 377–384.